Diagnostics

A new partnership aims to turn saliva into a data-rich asset, signaling a major shift in the health tech market from reactive treatment to proactive care.

A Cambridge medtech firm has formed a global advisory board to fast-track its revolutionary 10-minute stroke test, a strategic move to disrupt pre-hospital care.

A new company aims to fix a multi-billion dollar problem in drug development by using advanced biomarker tests to find the right patients before they even start.

For millions with the debilitating condition dysautonomia, diagnosis is a long, frustrating journey. A new technology promises to replace subjective guesswork with hard data.

A new $200K award isn't just a grant; it's a strategic bet on systems engineering to fix a diagnostic pathway where 70% of lung cancer cases are found too late.

YD Bio is expanding its U.S. lab network, but the real story is its strategy: turning diagnostic tests into a vast data engine to power the future of cancer research.

Neurophet's AI software, now at Raffles Medical, analyzes brain MRIs in minutes, offering a powerful new weapon in the fight against dementia and MS in Asia.

After completing massive studies, the Utah firm is readying an FDA submission that could move gold-standard diagnostics from the lab to your local clinic.

An Oxford startup's AI-powered blood test can detect cancer and heart disease in dogs from a single sample, heralding a shift from reactive to proactive care.

With €7.5M from Europe’s top innovation fund, a Belgian startup is not just correcting vision—it’s turning the eye into a window for our overall health.

A new company is launching an AI-powered specialty to detect cancer before it forms. But can this personalized, oncologist-led model overcome hurdles of cost and access?

A breakthrough melanoma test from SkylineDx has earned rare dual recognition, promising to reshape patient care by reducing unnecessary surgeries.

With a proven test but lagging sales, Sera Prognostics taps a diagnostics veteran to navigate the treacherous path from clinical validation to market success.

A new survey reveals a staggering disconnect: midlife women are ready for early Alzheimer's testing, but the healthcare system is failing to start the conversation.

Trinity Biotech, a diagnostics firm, is entering the $27B AI cooling market. Can its expertise in high-purity fluids solve the data center thermal crisis?

A new report shows a five-year low in student drug positivity rates, yet a deeper analysis reveals a complex landscape of risk shaped by fentanyl and synthetics.

The Association for Diagnostics & Laboratory Medicine's new leadership, led by Dr. Christina Lockwood, signals a decisive move to tackle healthcare's biggest challenges.

Exact Imaging's U.S. expansion signals a major shift. With technology rivaling MRI, micro-ultrasound is poised to make precision diagnostics more accessible.

Plus Therapeutics rebrands to Cerenome, signaling a major pivot to an integrated platform combining diagnostics, radiotherapeutics, and AI for CNS cancers.